Wednesday, 26 August 2026European Markets

LAVIDE HOLDING Stock Went Up By Over 20% So Far Today

Loading stream...

(VIANEWS) - Shares of LAVIDE HOLDING (AEX-Index: LVIDE.AS) rose by a staggering 20% to €0.30 at 14:07 EST on Tuesday, following the last session's upward trend. AEX-Index is falling 0.67% to €758.19, following the last session's downward trend. This seems, at the moment, a somewhat negative trend trading session today.

LAVIDE HOLDING's last close was €0.25, 53.53% under its 52-week high of €0.54.

About LAVIDE HOLDING

Lavide Holding N.V. does not have significant operations. Previously, it was engaged in the provision of integrated information technology solutions for medium to large-sized companies and organizations. The company was formerly known as Qurius N.V. and changed its name to Lavide Holding N.V. in July 2013. Lavide Holding N.V. was incorporated in 1998 and is based in Sluis, the Netherlands.

Earnings Per Share

As for profitability, LAVIDE HOLDING has a trailing twelve months EPS of €-0.04.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, LAVIDE HOLDING's stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

LAVIDE HOLDING's stock is valued at €0.30 at 14:07 EST, way under its 52-week high of €0.54 and way above its 52-week low of €0.14.

Volume

Today's last reported volume for LAVIDE HOLDING is 4022 which is 31.78% above its average volume of 3052.

More news about LAVIDE HOLDING (LVIDE.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
LAVIDE HOLDING Stock Went Up By Over 20% So Far Today | ViaNews EU